Menu
Search
|

Menu

Close
X

Dali Pharmaceutical Co Ltd 603963.SS (Shanghai Stock Exchange)

11.36 CNY
+0.06 (+0.53%)
As of Feb 15
chart
Previous Close 11.30
Open 11.31
Volume 1,373,048
3m Avg Volume 1,544,916
Today’s High 11.38
Today’s Low 11.21
52 Week High 31.23
52 Week Low 10.23
Shares Outstanding (mil) 130.00
Market Capitalization (mil) 1,476.80
Forward P/E 135.01
Dividend (Yield %) 0.08 ( 0.68 )

LATEST NEWS

ADVERTISEMENT

RECOMMENDATION

No Data Available
Sell Hold Buy

KEY STATS

Revenue (mm, CNY)
FY18
307
FY17
341
FY16
276
EPS (CNY)
FY18
0.042
FY17
0.669
FY16
0.638
*Note: Units in Millions of Renminbi
**Note: Units in Renminbi

KEY RATIOS

Price to Earnings (TTM)
vs sector
135.01
35.99
Price to Sales (TTM)
vs sector
3.84
10.11
Price to Book (MRQ)
vs sector
3.22
4.60
Price to Cash Flow (TTM)
vs sector
--
26.60
Total Debt to Equity (MRQ)
vs sector
0.00
16.95
LT Debt to Equity (MRQ)
vs sector
0.00
13.45
Return on Investment (TTM)
vs sector
2.36
12.72
Return on Equity (TTM)
vs sector
2.36
13.73

EXECUTIVE LEADERSHIP

COMPANY PROFILE

Sector: Healthcare
Industry: Pharmaceuticals
Address:

No.118, Huancheng West Road, Xia
DALI   YUN   671000

Phone: +86872.8880055

Dali Pharmaceutical Co., Ltd. is a China-based company principally involved in the production and sales of Chinese and western medicine injections. The Company’s main products include Xingnaojing injections and Shenmai injections. The other products include astragalus injections and mycorrhizal injections. Through its subsidiaries, the Company is also involved in the lease of offices and factory buildings, as well as the investment of equity.

SPONSORED STORIES